You're currently on:
Dorsomorphin, compound C is a cell-permeable pyrrazolopyrimidine derivative that inhibits AMP kinase in an ATP-competitive manner. Dorsomorphin displays no significant inhibition of ZAPK, SYKK, PKCT, PKA and JAK3. Dorsomorphin decreases food intake in mice and inhibits the effects of AICAR and metformin. Dorsomorphin has been shown to inhibit BMP type I receptors ALK2, ALK3 and ALK6.
Bone morphogenetic protein (BMP) are members of the transforming growth factor-β (TGF-β) superfamily determining embryonic patterning and tissue morphogenesis. The recent discovery of dorsomorphin, the first chemical inhibitor of BMP receptor signaling bone disease provides hope for future fibrodysplasia ossificans progressiva (FOP) therapies.
|Chemical Name||6-[4-(2-Piperidin-1-yl)-ethoxy)- phenyl)]-3-pyridin-4-yl- pyrazolo[1,5-a]-pyrimidine|
|Alternative Name||Compound C, AMPK INHIBITOR|
|Appearance||Light yellow solid|
|Handling||Protect from air&light|
|Solubility||Soluble in DMSO|
- Require bulk price at a prefered discount? Click Here.
Follow our latest scientific offerings with our blog. Click Here.
All products sold by AG Scientific are strictly for Laboratory, Preclinical Research, or Bioprocessing purposes only. They are not intended for Human Drug, Food Additive, Clinical or Household use.